N-cyclobutylpivalamide | 1339633-43-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-cyclobutylpivalamide
• 英文别名: N-cyclobutyl-2,2-dimethylpropanamide
• CAS: 1339633-43-0
• 化学式: C₉H₁₇NO
• 分子量: 155.24
• InChiKey: RIWNORAVEJYZSE-UHFFFAOYSA-N

物化性质

• 沸点：
  284.1±7.0 °C(Predicted)
• 密度：
  0.94±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-cyclobutylpivalamide 在 甲醇 、 dipotassium peroxodisulfate 、 palladium diacetate 、 potassium carbonate 作用下， 反应 20.0h， 生成 N-cyclobutyl-3-hydroxy-2,2-dimethylpropanamide
  参考文献：
  名称：

  Palladium-Catalyzed β-Acyloxylation of Simple Amide via sp³ C–H Activation

  摘要：

  beta-Acylcoxy amides are prepared in moderate to high yields by palladium-catalyzed acyloxylation of primary sp(3) C-H bonds from simple amides without any special directing group. A catalytic system of Pd(OAc)(2)/CF3CO2H/K2S2O8 is available to various amides with N-substituted by linear alkanes, cyclic alkanes, and electron-deficient benzyl compounds in this reaction. Acyloxylated products could be transformed easily to the corresponding beta-hydroxy amides.

  DOI：

  10.1021/ol403393w
• 作为产物：
  描述：

  环丁基胺 、 三甲基乙酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 N-cyclobutylpivalamide
  参考文献：
  名称：

  Palladium-Catalyzed β-Mesylation of Simple Amide via Primary sp³ C–H Activation

  摘要：

  A beta-mesylation of primary sp(3) C-H bonds from simple amides with methanesulfonic anhydride; (Ms2O) has been established successfully A 80 degrees C in a Pd(OAc)(2) (catalyst)/K2S2O8 (oxidant)CF3CH2OH (solvent) system. These amide substrates involve N-monosubstituted linear,, branch, or cyclic alkanes, and electron-deficient benzyl compounds. The beta-mesylated amide products can be converted easily to beta-fluoroamideS or beta-lactams through inter- or intramolecular S(N)2 processes.

  DOI：

  10.1021/acs.orglett.7b00536

文献信息

• TRIAZOLE ACC INHIBITORS AND USES THEREOF
  申请人：Gilead Apollo, LLC

  公开号：US20170166584A1

  公开（公告）日：2017-06-15

  The present invention provides triazole compounds useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, and methods of using the same.

  本发明提供了三唑化合物，可用作乙酰辅酶A羧化酶（ACC）的抑制剂，以及其组合物和使用方法。
• ESTER ACC INHIBITORS AND USES THEREOF
  申请人：Gilead Apollo, LLC

  公开号：US20170166583A1

  公开（公告）日：2017-06-15

  The present invention provides ester compounds useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, and methods of using the same.

  本发明提供了作为乙酰辅酶A羧化酶（ACC）抑制剂的酯化合物，以及其组合物和使用方法。
• DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS
  申请人：Molteni Valentina

  公开号：US20090012094A1

  公开（公告）日：2009-01-08

  Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.

  本文介绍了一种包含二芳胺结构特征的化合物。还介绍了制备这种化合物的方法，使用这种化合物调节c-kit受体活性的方法，以及包含这种化合物的制药组合物和药物。本文还介绍了使用这种化合物、制药组合物和药物治疗和/或预防和/或抑制和/或改善与c-kit受体活性相关的病理学和/或症状学疾病或状况的方法。
• Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors
  申请人：Molteni Valentina

  公开号：US20070149538A1

  公开（公告）日：2007-06-28

  Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.

  本文描述了包含二芳胺结构特征的化合物。还描述了制备这种化合物的方法，使用这种化合物调节c-kit受体活性的方法，以及包含这种化合物的药物组合物和药物。本文还描述了使用这种化合物、药物组合物和药物治疗和/或预防和/或抑制和/或改善与c-kit受体活性相关的病理学和/或症状学疾病或状况的方法。
• PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH
  申请人：Sloss Marianne

  公开号：US20090270418A1

  公开（公告）日：2009-10-29

  Provided herein are Pyrazole Pyrazine Amine Compounds having the following structure: Wherein Q and R 1 -R 3 are as defined herein, compositions comprising an effective amount of a Pyrazole Pyrazine Amine Compound and methods for treating or preventing inflammatory conditions, immunological conditions, cancer, neurodegenerative diseases, age-related diseases, cardiovascular diseases and metabolic conditions, or conditions treatable or preventable by inhibition of an IKK, or an IKK pathway, comprising administering an effective amount of a Pyrazole Pyrazine Amine Compound to a patient in need thereof.

  本文提供具有以下结构的吡唑吡嗪胺化合物：其中Q和R1-R3如本文所定义，包括有效量的吡唑吡嗪胺化合物的组合物以及用于治疗或预防炎症性疾病、免疫疾病、癌症、神经退行性疾病、与年龄相关的疾病、心血管疾病和代谢疾病，或通过抑制IKK或IKK途径可治疗或预防的疾病的方法，包括向需要治疗的患者投与有效量的吡唑吡嗪胺化合物。